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Malaria remains one of the prominent public health problems that lead to severe morbidity and mortality 
in many developing countries around the globe. New antimalarial drugs are urgently needed due to the 
emergence of antimalarial-resistant strains of Plasmodium falciparum. In previous studies, we tested 
several plants extracts that are capable of inhibiting β-hematin formation, with efficiency similar to 
chloroquine. In the current study, the effect of cinnamon ethanol and water extracts on inhibiting β-
hematin formation was studied. Powdered cinnamon extracts and bark in a stick form were investigated 
using various extraction methods. A semi-quantitative in vitro method, based on the inhibition of 
ferriprotoporphyrin IX (FP) bio-crystallization developed by Deharo et al. (2002) was utilized. Water 
extracts of cinnamon revealed potential activity even at low concentration of infusions, which was 
manifested by a high capability to inhibit β-hematin formation in vitro.  
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INTRODUCTION 
 
Malaria is a mosquito-borne infectious disease, caused 
by a plasmodium parasite that is transmitted to humans 
through the bites of infected anopheles mosquitoes. Five 
species of plasmodium parasites are responsible for 
malarial infection. However, Plasmodium falciparum 
species are the most fatal among the four other species 
(Rathore, 2006). 
According to recent World Health Organization (WHO) 
Malaria Report, about 198 million cases of malaria 
occurred globally in 2013 and the disease led to an 
estimated 584,000 deaths. The burden is the heaviest in 
the WHO African Region where an estimated 90% of all 
malaria deaths occur, mostly in children under five years 
of age. Therefore, malaria is considered to be one of the 
major life-threatening diseases (WHO, 2014). 
In the human host, the parasite develops through two 
main stages: exo-erythrocytic stage (in liver) and intra-
erythrocytic stage (in red blood cells, RBCs). During the 
intra-erythrocytic cycle, the trophozoite ingests the host 
cytoplasm forming a large food vacuole where the 
digestion of host hemoglobin takes place giving it the 
appearance of a ring of cytoplasm (Roberts et al., 1996). 
The parasite consumes up to 80% of the host cell 
hemoglobin in its vacuole (Moore et al., 2006). The
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digestion of hemoglobin releases hematin (oxidized 
heme), which is toxic to the parasite. Therefore, to avoid 
destruction by hematin, the parasite detoxifies the 
hematin through bio-crystallization (Pagola et al., 2000; 
Kumar et al., 2008) converting it into insoluble and 
chemically inert β-hematin crystals known as hemozoin 
or malaria pigment. 
Thus, considering the importance of hemozoin for 
parasite survival encouraged researchers to discover 
new antimalarial drugs that inhibit hemozoin 
biocrystallization leading to the release of high quantities 
of free heme, which is fatal to the parasite (Pandey and 
Chauhan, 1998). 
The emergence of antimalarial-resistant plasmodium 
strains instigates research endeavors to discover new 
antimalarial drugs. The process of hematin 
polymerization is essential for the survival of the malarial 
parasite. Chloroquine, a well-known quinoline derivative 
inhibits this process by interfering with β-hematin 
formation, through the formation of a complex with free 
hematin molecules (Slater et al., 1991; Kumar et al., 
2007). Several other quinolones also inhibit the 
polymerization process of free hematin (Slater, 1993). 
Throughout history, plants have been used for medical 
purposes. They are effective, cheap, available, have 
fewer side effects and can be used as an alternative to 
mainstream medicines (Ghosh, 2003). Numerous natural 
plants that are known in folk medicine were tested for β-
hematin formation inhibition to develop effective 
antimalarial drugs. We had previously investigated active 
extracts from Salvia officinalis (Akkawi et al., 2012), wild 
Salvia palaestina leaves (Jaber et al., 2013), Artemisia 
annua herb in comparison to Palestinian Artemisia sieberi 
(Akkawi et al., 2014). 
Cinnamon is one of the oldest herbal medicines that 
have been mentioned in Chinese texts as early as 4000 
years ago (Torizuka, 1998), and has been traditionally 
harvested in Asian countries. It is an ever green tree, 
which belongs to the family Lauraceae. It is available as 
Cinnamon chips (like wood chips), rolled into Cinnamon 
sticks or ground into cinnamon powder. Numerous health 
benefits of Cinnamon were reported, such as anti-
bacterial, anti-microbial (Singh et al., 2007), anti-oxidant, 
anti-fungal (Tabassum and vidyasagar, 2013) and anti-
diabetic (Kannappan et al., 2006). 
It contains a hepatotoxic molecule called coumarin 
(~1%), which is unsafe when taken in high-doses and for 
long-term use. It is safe within a dosage range of 1 to 6 g 
daily (Medagama and Bandara, 2014). No major 
reactions have been reported with doses of less than 6 g 
per day. In the current investigation, a screening of the in 
vitro potential inhibitory effect of different water extracts 
of cinnamon on β-hematin formation was established. 
 
 
MATERIALS AND METHODS 
 
Dimethyl sulfoxide (DMSO) of 99.5% purity was purchased from  
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Sigma Aldrich. Chloroquine diphosphate salt was purchased from 
Sigma. Glacial acetic acid was purchased from Fluka. Sodium 
acetate of 99% purity was purchased from Aldrich. Hemin chloride 
was purchased from Sigma. Cinnamon was provided from a local 
market in Palestine. 
 
 
Extraction of plant component 
 
Infusion of cinnamon powdered bark [Method-A] 
 
Two grams of cinnamon fine-powdered bark was soaked in 150 ml 
of hot distilled water (at 90°C), and left for 30 min at room 
temperature, then filtered using MN 615.Ø110 mm filter paper. The 
extract then was evaporated at 70°C under reduced pressure using 
(IKA WEREK RV06-ML) rotary evaporator, and a crude water 
extract was obtained. Then, it was lyophilized using Labconco 
freeze drier, until constant weight was achieved. The final dried 
extract was stored in opaque bottles and kept in a desiccator until 
use. 
 
 
Preparation of cinnamon bark (sticks) extract [Method-B] 
 
Cinnamon bark water decoction [Method-B1] 
 
Four grams (one stick) of cinnamon bark was boiled in 300 ml of 
distilled water for 20 min, and left for 30 min at room temperature, 
and then filtered using MN 615.Ø110 mm filter paper. 
 
 
Cinnamon bark water infusion [Method-B2] 
 
Four grams (one stick) of cinnamon bark was soaked in 300 ml of 
hot distilled water (at 90°C), and left for 30 min at room 
temperature, then filtered using MN 615.Ø110 mm filter paper. The 
results of Figure 3 correspond to this extraction method. 
 
 
Preparation of cinnamon powdered bark alcoholic extract 
[Method-C] 
 
Two grams of cinnamon powdered bark was soaked in 150 ml of 
20% ethanol, and left for about 20 min at room temperature, and 
then filtered using MN 615.Ø110 mm filter paper. Same method 
was prepared using 35% ethanol. The results of Figure 4 
correspond to this extraction method. 
 
 
In vitro semi-quantitative test for screening the inhibition of β-
hematin formation 
 
As per Deharo et al. (2002) method, a mixture containing 50 μl of 
0.5 mg/ml hemin chloride freshly dissolved in DMSO, 100 μl of 0.5 
M sodium acetate buffer (pH 4.4), and 50 μl of the tested potential 
anti-malarial drug solution or control was incubated in a normal 
non-sterile 96-well flat bottom plate at 37°C for 18 to 24 h. It is 
important that the solutions be added to the plate in this order. The 
plate was then centrifuged for 10 min at 4000 rpm. The supernatant 
was removed and the pH of reaction was measured. The final pH of 
the mixture should be between 5.0 and 5.2. The wells were washed 
with 200 μl DMSO per well to remove free hemin chloride. The plate 
was centrifuged again, discharging the supernatant afterwards. The 
β-hematin remaining was then dissolved in 200 μl of 0.1 M NaOH to 
form an FP that can be measured spectrophotometrically.  
Finally, the absorbance was read at 405 nm using ELISA reader. 
Ultra-pure water was used as negative control. Chloroquine (CQ) 
and 2-mercaptopyrimidine (2-MP) were dissolved in ultra-pure
1000         J. Med. Plants Res. 
 
 
 
 
 
Figure 1. Column diagram representing the efficacy of cinnamon powdered bark water infusion using [method A], compared to the 
negative and positive controls: ultra-pure H2O and CQ 0.1 mg/ml, respectively, showing the absorption values of dissolved β-
hematin (alkaline hematin) at 405 nm using ELISA reader. 
 
 
 
water and both used as a positive control. 
 
 
Chromatographic analysis 
 
HPLC instrumentation system  
 
The analytical high pressure liquid chromatography (HPLC) system 
consists of Waters e2695 Alliance Module 2998-Photodiode Array 
detector (PDA). Data acquisition and control were carried out using 
Empower 3 software (Waters, Germany).  
 
 
Chromatographic conditions 
 
The HPLC analytical experiments were run on C18 column (Waters 
× Bridge, 4.6 × 150 mm, 5 μm). The flow rate was 1 ml/min. The 
injection volume was 10 l of 1 mg/ml of the dried bark extract. 
Analysis was performed at room temperature. The mobile phase 
consisted of water and acetonitrile solvents in the gradient mode. 
The linear gradient used was started with 98% water for 2 min and 
then raised linearly to 100% acetonitrile in 20 min. Before analysis, 
the column was equilibrated with the starting mixture for 15 min. 
The PDA scans a range of wavelengths from 210 to 400 nm. 
Wavelengths of 220 and 275 nm were extracted for peaks 
comparison.  
RESULTS 
 
Results of infusions and dilutions made in distilled water 
(method-A) are shown in Figure 1. Each absorption value 
is the average of 32 experiments. Figure 2 shows the 
antimalarial activity of lyophilized cinnamon water 
infusion (Method-A). Each absorption value is the 
average of 24 experiments. A comparison between 
cinnamon bark water decoction traditional method 
(Method-B1) and cinnamon bark water infusion (Method-
B2) is shown in Figure 3. Each result represents the 
average of 8 individual experiments. Figure 4 represents 
a comparison between 20 and 35% ethanol extract of 
cinnamon powdered bark.Each result represents the 
average of 8 individual experiments. 
At this stage of the study, we tried to learn more about 
the crude water-soluble peaks profile, numbers, retention 
times as well as their corresponding UV-Vis spectra using 
HPLC-PDA. Infusion of cinnamon powdered bark 
(extraction using method-A) was dissolved in pure water, 
filtered and injected freshly to the HPLC-PDA. Figure 5 
shows the peaks at 220 nm and 275 nm, respectively.
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Figure 2. Column diagram representing the efficacy of lyophilized cinnamon powdered bark water infusion 
using method A, compared to the negative control; ultra-pure H2O and positive controls: CQ 0.1 mg/ml and 
2-MP (2-mercaptopyrimidine) 1 mg/ml, showing the absorption values of dissolved β-hematin (alkaline 
hematin) at 405 nm using ELISA reader. 
 
 
 
 
 
Figure 3. Column diagram representing a comparison of the efficacy between cinnamon water decoction [method-B1] and infusion 
[method-B2], compared to the negative control; ultra-pure H2O and positive controls: CQ 0.1 mg/ml and 2-MP (2-mercaptopyrimidine) 1 
mg/ml, showing the absorption values of dissolved β-hematin (alkaline hematin) at 405 nm using ELISA reader. 
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Figure 4. Column diagram representing a comparison of the efficacy between 20 and 35% ethanol extract of cinnamon powdered 
bark [method-C], compared to the negative control ultra-pure H2O and positive controls: CQ 0.1 mg/ml, showing the absorption values 
of dissolved β-hematin (alkaline hematin) at 405 nm using ELISA reader. 
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Figure 5. HPLC-PDA peak profiles of crude cinnamon at two wavelengths, 220 and 275 nm, respectively. 
 
 
 
Figure 6 shows the UV-Vis absorption spectrum of the 
major peak that exhibit a maximum wavelength of 275.8 
nm      and   309.  1   nm,   respectively.  Using  PDA,  the 
scanned UV-Visible spectra from 210-400 nm of the 
major peaks exist in the crude water extract is shown in 
Figure 7. 
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Figure 6. UV-Visible spectrum of main peak cinnamic acid present in crude cinnamon eluted at 11.1 min. 
 
 
 
DISCUSSION 
 
The results acquired were compared to negative ultra-
pure H2O and positive chloroquine (CQ) of 0.1 mg/ml and 
2-mercaptopyrimidine (2-MP) of 1 mg/ml controls. 2-MP 
is considered as an internal control to ensure that the 
reaction environment was ideal, that is, due to its 
sensitivity to the change in temperature. The absorption 
is inversely proportional to drug efficiency meaning the 
lower the absorption, the more efficient the drug is. 
The boiled extract of Method-B1 was found to be more 
effective than that of Method-B2 as shown in Figure 3, 
because more therapeutic compound is expected to be 
released when decoction is performed. 
Cinnamon powdered bark water infusion provides 
better results than cinnamon bark sticks, probably due to 
its higher surface area and small volume that allow its 
active ingredients to dissolve better. 
From Figure 4, it is evident that  the  extract  acts  more 
efficiently in the 20% alcoholic extract rather than the 
35% alcoholic extract. This observation probably 
indicates the capability of water to extract efficient 
compounds by using this ratio. 
Inhibiting heme polymerization “β-hematin formation” of 
different antimalarial drugs, such as chloroquine  through  
complex formation of with ferriheme monomers has been 
studied by different spectroscopic methods (Dorn et al., 
1995; Blauer et al., 1982). 
The activity of cinnamon water infusions is thought to 
be by inhibition of β-hematin formation which is probably 
through formation of a complex between ferriheme and 
the reactive groups of compounds found in the cinnamon 
infusion. Different non-covalent interactions may be 
responsible for this inhibition. For example, the possibility 
of forming hydrogen bonding between propionic acid in 
ferriheme and corresponding hydrogen-bonding groups 
found of the active compounds in the cinnamon infusion, 
carbonyl groups, as an example. In addition, π-π electron
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Figure 7. Overlaid other major UV-Visible spectra of the peaks present in crude water cinnamon extract. The colored 
numbers at the right corner represent  the retention time of each eluted peak.
 
 
 
interactions between proximate heterocyclic and aromatic 
moieties of the complex components could add to the 
stability of the complex. 
In the literature, the bark of various cinnamon species 
were investigated using GC-MS for the most important 
constituents of cinnamon essential oil, which contribute to 
the fragrance and some biological activities observed in 
cinnamon oil. Among these are trans-cinnamaldehyde 
(65 to 80%), eugenol (5 to 10%) and some other 
compounds, which present to a lesser extent, such as 
cinnamic acid, p-methoxycinnamaldehyde, hydroxyl 
cinnamaldehyde, cinnamyl alcohol, cinnamyl acetate, 
coumarin, α-muurolene and borneal (Rao and Gan, 2014; 
Kamaliroosta et al., 2012). The water extracts however, 
revealed more phenolic glycosides and cinnacassosides 
constituents (Luo et al., 2013). 
From the results obtained after performing HPLC-PDA 
for cinnamon powdered bark infusion (extraction using 
method-A), Figure 5, and at 220 nm, the chromatogram 
manifested more peaks although both indicated a major 
one at about 11.1 min. While Figure 6 shows the UV-Vis 
absorption spectrum of the major peak that exhibit a 
maximum wavelength of 275.8 and 309.1 nm, 
respectively  similar  to  typical  cinnamic  acid,  a  soluble 
 
 
 
compound in water. Other peaks eluted between 12 and 
19 min gave UV-Vis maxima at 287, 307, 309 and 337 
nm. Moreover, a bunch of hydrophilic compounds were 
eluted in close proximity and overlapped between the 
ranges of 5 to 9 min (Figures 5 and 7). Longer and slower 
gradient elution in future investigation would show better 
resolution of this region. Currently, this study is focusing 
on the preparative HPLC separation of the major peaks 
to characterize their structures.  
 
 
Conclusion 
 
Due to the emergence of antimalarial-resistant strains of 
P. falciparum, there is an urgent need to search for new, 
safe, effective, and cheaply available anti-malarial drugs 
from natural products. Using the ferriprotoporphyrin bio-
crystallization inhibition test, this study revealed 
cinnamon's crude water soluble extracts ability to inhibit 
β-hematin formation in vitro. Therefore, this endeavor 
must be given more attention to identify its active β-
hematin agent. 
Fractionation, purification and identification of the 
possible potential active  ingredients  as  well  as  in  vitro 
 
 
 
 
testing are currently under investigation. 
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